Novan is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. It develops NITRICIL technology that allows the control of the level of nitric oxide storage, the rate of release, and the molecule size for targeted delivery.